Ocugen (OCGN) News Today $1.56 -0.16 (-9.06%) As of 01:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OCGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Ocugen (NASDAQ:OCGN) Shares Down 7.4% - Should You Sell?October 11 at 12:36 PM | marketbeat.comWeiss Ratings Reaffirms Sell (E+) Rating for Ocugen (NASDAQ:OCGN)October 10 at 8:22 AM | marketbeat.comOcugen to Highlight Gene Therapy Pipeline at Key Industry and Investor ConferencesOctober 6, 2025 | msn.comOcugen (NASDAQ:OCGN) Hits New 52-Week High - Here's WhyOctober 3, 2025 | marketbeat.comOcugen to Present at Industry and Investor Conferences in October 2025October 2, 2025 | markets.businessinsider.comOcugen to Present at Major Biotechnology Conferences Focused on Advancements in Gene Therapies for Blindness DiseasesOctober 2, 2025 | quiverquant.comQTraders Buy High Volume of Ocugen Call Options (NASDAQ:OCGN)October 1, 2025 | marketbeat.comGoldman Sachs Group Inc. Lowers Holdings in Ocugen, Inc. $OCGNSeptember 27, 2025 | marketbeat.comOcugen (NASDAQ:OCGN) Reaches New 52-Week High - Time to Buy?September 24, 2025 | marketbeat.comOcugen: A Retinal Disease Juggernaut In The MakingSeptember 23, 2025 | seekingalpha.comOcugen (NASDAQ:OCGN) Earns Buy Rating from Chardan CapitalSeptember 20, 2025 | marketbeat.com200,100 Shares in Ocugen, Inc. $OCGN Purchased by Procyon Advisors LLCSeptember 20, 2025 | marketbeat.comOcugen Strikes $187.5 Million Licensing Deal With Kwangdong for Gene Therapy in KoreaSeptember 20, 2025 | msn.comOcugen (NASDAQ:OCGN) Upgraded by Wall Street Zen to Hold RatingSeptember 20, 2025 | marketbeat.comForecasting The Future: 4 Analyst Projections For OcugenSeptember 19, 2025 | benzinga.comOcugen (OCGN): Evaluating Valuation Following Exclusive Korean Licensing Deal for Gene Therapy OCU400September 18, 2025 | finance.yahoo.comWhy Ocugen (OCGN) Is Up 16.5% After Licensing OCU400 Gene Therapy Rights to KwangdongSeptember 16, 2025 | finance.yahoo.comOcugen Signs Exclusive License Agreement with KwangdongSeptember 16, 2025 | tipranks.comOcugen executes licensing agreement with Kwangdong PharmaceuticalSeptember 15, 2025 | msn.comOcugen, Inc. Announces Licensing Agreement with Kwangdong Pharmaceutical for OCU400, Potentially Worth Up to $187.5 MillionSeptember 15, 2025 | quiverquant.comQOcugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in KoreaSeptember 15, 2025 | globenewswire.comNuveen LLC Takes Position in Ocugen, Inc. $OCGNSeptember 7, 2025 | marketbeat.comOcugen CEO to Speak at Investor Conferences in New York and MunichSeptember 6, 2025 | msn.comOcugen Enters Subscription Agreement with Carisma TherapeuticsSeptember 5, 2025 | tipranks.comCarisma Therapeutics stock soars after merger agreement with OcugenSeptember 3, 2025 | au.investing.comOcugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025September 2, 2025 | finance.yahoo.comOcugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025September 2, 2025 | globenewswire.comGMT Capital Corp Grows Position in Ocugen, Inc. $OCGNSeptember 1, 2025 | marketbeat.comOcugen (NASDAQ:OCGN) Stock Price Up 3% - Here's WhyAugust 27, 2025 | marketbeat.comOcugen IncAugust 25, 2025 | edition.cnn.comOcugen reports EMA positive advice for acceptability of OCU410STAugust 13, 2025 | msn.comOcugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt DiseaseAugust 13, 2025 | globenewswire.comOcugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and WarrantsAugust 12, 2025 | globenewswire.comOcugen, Inc. Announces $20 Million Securities Purchase Agreement with Janus Henderson InvestorsAugust 8, 2025 | quiverquant.comQOcugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and WarrantsAugust 8, 2025 | globenewswire.comFY2025 EPS Estimates for Ocugen Increased by Chardan CapitalAugust 8, 2025 | marketbeat.comHC Wainwright Has Positive Outlook of Ocugen FY2025 EarningsAugust 8, 2025 | marketbeat.comOcugen's (OCGN) "Buy" Rating Reiterated at Chardan CapitalAugust 5, 2025 | marketbeat.com3OCGN : Demystifying Ocugen: Insights From 5 Analyst ReviewsAugust 4, 2025 | benzinga.comOcugen (NASDAQ:OCGN) Posts Earnings Results, Beats Expectations By $0.01 EPSAugust 4, 2025 | marketbeat.comOcugen, Inc. (NASDAQ:OCGN) Q2 2025 Earnings Call TranscriptAugust 2, 2025 | msn.comOcugen Inc’s Earnings Call: Progress Amid Financial ChallengesAugust 2, 2025 | msn.comOcugen Reports Progress in Gene Therapy TrialsAugust 1, 2025 | tipranks.comOcugen Wins Dismissal of Securities LawsuitAugust 1, 2025 | theglobeandmail.comOcugen (OCGN) Q2 Revenue Jumps 20%August 1, 2025 | fool.comOcugen, Inc. (OCGN) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | seekingalpha.comOcugen Provides Business Update with Second Quarter 2025 Financial ResultsAugust 1, 2025 | globenewswire.comOcugen Q2 2025 Earnings PreviewAugust 1, 2025 | msn.comGSA Capital Partners LLP Increases Stake in Ocugen, Inc. (NASDAQ:OCGN)July 31, 2025 | marketbeat.comOcugen (OCGN) to Release Quarterly Earnings on FridayJuly 25, 2025 | marketbeat.com Get Ocugen News Delivered to You Automatically Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OCGN Media Mentions By Week OCGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCGN News Sentiment▼0.870.77▲Average Medical News Sentiment OCGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCGN Articles This Week▼54▲OCGN Articles Average Week Get the Latest News and Ratings for OCGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ocugen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Moderna News Pfizer News ANI Pharmaceuticals News Vera Therapeutics News Twist Bioscience News Ocular Therapeutix News Apogee Therapeutics News Cogent Biosciences News Dyne Therapeutics News AbCellera Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCGN) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocugen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
